期刊文献+

SPIO标记的c-erbB2反义探针用于活体荷瘤裸鼠MRI的最佳扫描浓度 被引量:4

Optimal concentration of c-erbB2 antisense probe labeled with superparamagnetic iron oxide nanoparticles for magnetic resonance imaging in tumor-bearing nude mice
在线阅读 下载PDF
导出
摘要 目的探讨SPIO标记的c-erbB2反义寡脱氧核苷酸探针用于活体荷瘤裸鼠MRI的最佳扫描浓度。方法 BALB/c荷瘤裸鼠30只,随机分为5组并每组注射不同浓度反义探针(含Fe 6.0、9.0、12.0、15.0、18.0 mg/kg),每组裸鼠于既定的时间点(注射前、注射后360 min)同步行MRI扫描。在完成MR扫描后,立即处死荷瘤裸鼠,取出肿瘤组织,行HE及普鲁士蓝染色,光学显微镜下观察;测量肿瘤组织在注射不同浓度反义探针前后的信号强度变化。结果成功建立荷瘤裸鼠模型,成瘤率100%。6.0、9.0及12.0 mg组裸鼠注射探针后均存活,但15.0 mg组及18.0 mg组注射探针及扫描完成后存在部分裸鼠死亡;对比荷瘤裸鼠肿瘤组织在不同浓度反义探针注射前后的信号强度变化,发现12.0、15.0及18.0 mg组裸鼠在注射探针后,肿瘤组织信号强度变化更具显著性(P<0.001);肿瘤组织信号强度均明显变化并可达到明显肉眼辨识水平,在MR扫描图像上能够清楚显示,并且12.0 mg组、15.0 mg组及18.0 mg组的统计学差异无显著性(P>0.05)。HE染色发现肿瘤组织结构紊乱,存在大量异性肿瘤细胞,排列呈"癌巢"状,在各浓度组表现相似;而普鲁士蓝染色发现各浓度组的肿瘤组织标本中均散在分布斑点状蓝色铁颗粒,12.0 mg组、15.0 mg组及18.0 mg组分布均密集明显。结论 SPIO标记的c-erbB2反义寡脱氧核苷酸探针能靶向于肿瘤组织,用于BALB/c裸鼠MRI的最佳扫描浓度为含Fe 12.0 mg/kg。 Objective To determine the optimal concentration of c-erbB2 antisense probe labeled with superparamagnetic iron oxide(SPIO) nanoparticles for in vivo tumor imaging in mice using magnetic resonance imaging(MRI).Methods Thirty BALB/c mice bearing SK-Br-3 tumor were randomized into 5 groups to receive injections of different concentrations of SPIO-labeled c-erbB2 antisense probe(containing 6.0,9.0,12.0,15.0,or 18.0 mg Fe/kg).MRI was performed before and 6 h after the injections,and the signal intensities of the tumor were compared among the groups.The tumor tissues were then dissected for microscopic examination with HE and Prussian blue staining.Results The tumor-bearing mice all survived after injections of the probe at doses of 6.0,9.0 and 12.0 mg,but injections at higher doses(15.0 and 18.0 mg) caused death in some mice. Injections of the probe at the doses of 12.0,15.0 and 18.0 mg resulted in significant signal enhancement of the tumor(P0.001) to allow visual identification,but the changes showed no significant differences among the 3 groups(P0.05).Pathological examination revealed irregular structures of the tumor issue containing numerous heterogenous tumor cells aligned into cancer nests;Prussian blue staining visualized scattered blue iron particles in the tumor issue,which was especially obvious in mice injected with 12.0,15.0 and 18.0 mg labeled probe.Conclusion Injection of 12.0 mg/kg SPIO-labeled c-erbB2 antisense probe allows optimal tumor imaging in BALB/c mice using MRI.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第4期496-501,共6页 Journal of Southern Medical University
基金 国家自然科学基金(30940021) 重庆市自然科学基金(CSTC2008BB5209) 重庆市卫生局医学科研基金(062029)~~
关键词 超顺磁氧化铁 反义探针 活体动物 MRI 扫描浓度 superparamagnetic iron oxide antisense probe magnetic resonance imaging scan concentration
作者简介 温志鹏,硕士,E—mail:link008316@163.com 通信作者:文明,博士,教授,硕士生导师,E-mail:13883669699@163com
  • 相关文献

参考文献16

  • 1Kircher MF, Willmann JK. Molecular body imaging: MR imaging, CT, and US. Part Ⅱ. Applications [J]. Radiology, 2012, 264(2):349-68.
  • 2Wen M, Li B, Bai W, et al. Application of atomic force microscopy in morphological observation of antisense probe labeled with magnetism[J]. Mol Vis, 2008, 14(1): 114-7.
  • 3Wen M, Li B, Ouyang Y, et al. Preparation and quality test of superpararnagnetic Iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study [J]. Ann Biomed Eng, 2009, 37(6): 1240-50.
  • 4谭书德,欧阳羽,文明,李梦雅.超顺磁性氧化铁标记的反义探针在动物体内的药动学及主要脏器分布研究[J].中国药学杂志,2011,46(21):1656-1660. 被引量:4
  • 5谢娟,李少林,张玉诺,刘方欣.^(99m)Tc标记c-erbB2反义寡脱氧核苷酸对乳腺癌显像的实验研究[J].中华医学杂志,2005,85(41):2940-2942. 被引量:4
  • 6文明,宋琳,柏玮,李少林,李必波.纳米级超顺磁性氧化铁的制备及其对小鼠急性毒性作用的观察[J].第二军医大学学报,2007,28(10):1104-1108. 被引量:7
  • 7Kievit FM, Zhang M. Surface engineering of Iron oxide nanoparticles for targeted cancer therapy[J]. Ace Chem Res, 2011, 44(10): 853-62.
  • 8Yallapu MM, Othman SF, Curtis ET, et al. Multi-fimctional magnetic nanoparticles for magnetic resonance imaging and cancer therapy [J]. Biomaterials, 2011, 32(7): 1890-905.
  • 9Lin MM, Kim HH, Kim H, et al. Surface activation and targeting strategies of superparamagnetic Iron oxide nanoparticles in cancer- oriented diagnosis and therapy[J]. Nanomedicine, 2010, 5(1): 109-33.
  • 10Bogdanov A Jr, Mazzanti ML. Molecular magnetic resonance contrast agents for the detection of cancer: past and present [J]. Semin Oncol, 2011, 38(1): 42-54.

二级参考文献37

  • 1王国斌,夏泽锋,陶凯雄,周立国,刘敬伟,肖勇,李剑星.医用纳米级Fe_3O_4磁流体的急性毒理学实验研究[J].华中科技大学学报(医学版),2004,33(4):452-454. 被引量:14
  • 2谢娟,刘方欣,王颖,李少林.^(99)Tc^m-EC-ASODN反义探针的合成和标记[J].核技术,2005,28(6):449-453. 被引量:7
  • 3文明,李少林.磁共振成像用于分子影像学研究[J].中国医学影像技术,2007,23(1):147-150. 被引量:24
  • 4文明,柏玮,李少林.SPIO磁共振对比剂的制备与应用现状[J].实用放射学杂志,2007,23(7):983-985. 被引量:8
  • 5Weissleder R. Molecular imaging : exploring the next frontier [J]. Radiology, 1999, 212(3) :609-614.
  • 6Weissleder R, Pittet MJ. Imaging in the era of molecular oncology [J]. Nature, 2008, 452(7187) :580-589.
  • 7Hu FQ, Wei L, Zhou Z, et al. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer [ J]. Adv Mater, 2006, 18 (19) : 2553- 2556.
  • 8Li Z, Wei L, Gao MY, et al. One-pot reaction to synthesize biocompatible magnetite nanoparticles [ J]. Adv Mater, 2005, 17 ( 8 ) : 1002-1005.
  • 9Weissleder R, Mahmood U. Molecular imaging [J]. Radiology, 2001, 219(2) :316-333.
  • 10McCarthy J, Weissleder R. Multifuncfional magnetic nanoparticles for targeted imaging and therapy [ J]. Adv Drug Deliv Rev, 2008, 60(11) :1241-1251.

共引文献41

同被引文献44

  • 1温志鹏,刘海燕,文明,贺海容,谭书德,李少林.SPIO标记的c-erbB2反义探针用于活体荷瘤裸鼠MR的最佳扫描时间探讨[J].四川大学学报(医学版),2013,44(5):708-712. 被引量:3
  • 2SIEGEL R, MA Jiemin, ZOU Zhaohui, et al. Cancer statis- tics, 2014 [J]. CA Cancer J Clln, 2014, 64(1): 9-29.
  • 3ITTRICH H, PELDSCHUS K, PELDSCHUS K, et al. Su- perparamagnetie iron oxide nanopartieles in biomedieine: ap- plications and developments in diagnostics and therapy [J]. Rofo, 2013, 185(12): 1149-1166.
  • 4LEE J H, HUH Y M, JUN Y W, et al. Artificially engi- neered magnetic nanoparticles for ultra-sensitive molecular imaging [J]. Nat ivied, 2097, 13(1) : 95-99.
  • 5KAIDA S, CABRAL H, KUMAGAI M, et al. Visible drug delivery by supramolecular nanocarriers directing to sngle-pat- formed diagnosis and therapy of pancreatic tumor model [J]. Cancer Res, 2010, 70(18): 7031-7041.
  • 6HADJIPANAYIS C G, MACHAIDZE R, KALUZOVA M A, et al. EGFRvIII antibody-conjugated iron oxide nanoparti- cles for magnetic resonance imaging-guided convection-en- hanced delivery and targeted therapy of glioblastoma [J]. Cancer Res, 2010, 70(15): 6303-6312.
  • 7YANG L, MAO Hui, WANG Y A, et al. Single chain epi- dermal growth factor receptor antibody conjugated nanoparti- cles for in vivo tumor targeting and imaging [J]. Small, 2009, 5(2): 235-243.
  • 8SUN C, LEE J S H, ZHANG M. Magnetic nanopartieles in MR imaging and drug delivery [J]. Advanced Drug Delivery Reviews, 2008, 60(11) : 1252-1265.
  • 9PYKE C, RALFKIAER E, RONNE E, et al. Immunohisto- chemical detection of the receptor for urokinase plasminogen activator in human colon cancer [J]. Histopathology, 1994, Z4(2) :131-138,.
  • 10PYKE C, GRAEM N, RALFKIAER E, et al. Receptor for urokinase is present in tumor-associated macrophages in duc- tal breast carcinoma [J]. Cancer Res, 1993, 53 (8) : 1911- 1915.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部